
Industrial & Financial Services · NSE / BSE
Mukka Proteins Limited, founded in March 2003, is a leading manufacturer of fish protein products, supplying fish meal, fish oil, and fish soluble paste to the aqua feed, poultry feed, and pet food industries. With a global footprint spanning over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam, the company ensures high-quality production through its six strategically located coastal facilities in India and Oman, along with three blending plants and five storage facilities in India. Certified by NQA and UKAS for ISO 22000:2018 and ISO 9001:2015, Mukka Proteins upholds stringent quality and food safety standards. Additionally, the company leverages contractual partnerships with third-party manufacturing facilities in Karnataka (Sasihithlu and Udupi) and Maharashtra (Taloja and Ratnagiri). Supported by a dedicated workforce of 385 employees across technical, administrative, and managerial roles, Mukka Proteins continues to strengthen its position as a key player in the global fish protein manufacturing industry through excellence in operations, adherence to international standards, and strategic expansion.
Price Band
₹26 – ₹28
Issue Size
₹224 Cr
Lot Size
535 shares
GMP
+125.0%
Est. Listing
₹63
at current GMP
Subscribed
136.89x
overall
Open
29 Feb 2024
Close
4 Mar 2024
Allotment
6 Mar 2024
Refund
7 Mar 2024
Demat Credit
8 Mar 2024
Listing
7 Mar 2024
Overall Subscription
136.89x
Total Demand
QIB Multiplier
189.28x
Institutions & Funds
NII / HNI
250.26x
High Net-Worth
Retail (RII)
58.36x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 16,000,435 | 3,028,531,210 | 189.28x |
| NIB | 12,000,000 | 3,003,083,935 | 250.26x |
| HNIs(10L +) | 8,000,000 | 2,033,180,830 | 254.15x |
| HNIs (2-10L) | 4,000,000 | 969,903,105 | 242.48x |
| RETAIL | 28,000,000 | 1,634,137,170 | 58.36x |
| Total | 68,000,435 | 10,668,836,250 | 136.89x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 52,336 | 3,054,329 | 58.36x |
| HNIs (10L +) | 335 | 83,837 | 250.26x |
| HNIs (2-10L) | 1,602 | 400,917 | 250.26x |
| Total Applications | 54,273 | 3,539,083 | 65.21x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Mukka Proteins Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹224 Crores. The shares are offered at a price band of ₹26 to ₹28 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-03-04, the basis of allotment is scheduled to be finalized on 2024-03-06. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Cameo Corporate Services Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Mukka Proteins Limited IPO is ₹35 per equity share. Based on the upper price band of ₹26 to ₹28 per equity share, the estimated listing price is ₹63 (+125.0% expected listing gain).
With a lot size of 535 shares and current GMP of ₹35, the expected profit per application lot is approx ₹18,725 (+125.0% gain). Minimum application cost is approx ₹14,980.
The Mukka Proteins Limited IPO aggregate issue size is ₹224 Crores with an equity price band set at ₹26 to ₹28 per equity share. The retail lot size is 535 shares requiring a minimum capital outlay of approx. ₹14,980.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 136.89x (Retail: 58.36x, QIB: 189.28x, NII: 250.26x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Cameo Corporate Services Limited) and the BSE status verification website on or around 2024-03-06. Investors can verify status using PAN card or application number.
Mukka Proteins Limited shares are scheduled to list on NSE and BSE on 2024-03-07.